Overview

Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
This study will assess whether olanzapine and/or risperidone affect the way the human body uses sugar in the blood.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Olanzapine
Risperidone